Tocut, Milena
Zohar, Iris
Schwartz, Orna
Yossepowitch, Orit
Maor, Yasmin
Article History
Received: 8 January 2022
Accepted: 13 June 2022
First Online: 24 June 2022
Declarations
:
: This study was approved by E. Wolfson Institutional Review Board (approval no: 0035-20-WOMC) and included a waiver of informed consent due to the retrospective nature of this study. The study was performed according to the Declaration of Helsinki. Data was obtained from the hospital registry.
: Not Applicable as there is no identifiable information (image, face, name etc.) of participant is revealed in the submission.
: We declare that the authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper. Yasmin Maor received an educational grant and lecture fees from Pfizer and lecture fees from MSD. Milena Tocut, Iris Zohar, Orna Schartz, and Orit Yossepowitch have no conflict of interests.